SCHEMBL12428434

SCHEMBL12428434

[C-]#[N+]/C(=C\C1=NN(c2ccccc2)C(=O)/C1=C\c1ccc(-c2ccc3c(c2)CCCN3c2cc(C)cc(C)c2)s1)C(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 2/20 0.34
HDAC6 Q9UBN7 1/20 0.34
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
ALDH1A1 P00352 4/20 0.34
MAPT P10636 4/20 0.34
KDM4E B2RXH2 3/20 0.34
HPGD P15428 3/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
HTT P42858 2/20 0.34
LMNA P02545 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
MAPK1 P28482 1/20 0.34
RECQL P46063 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HKDC1 Q2TB90 1/20 0.32
PRF1 P14222 1/20 0.32
GAA P10253 1/20 0.31
SCN9A Q15858 1/20 0.31
CREBBP Q92793 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12510398 0.88 MAPT (0.36) EP300HDAC6MEN1KMT2AALDH1A1
SCHEMBL12428433 0.81 MAPT (0.39) EP300HDAC6MEN1KMT2AALDH1A1
SCHEMBL12428249 0.80 EP300 (0.41) EP300HDAC6MEN1KMT2AALDH1A1
SCHEMBL12428261 0.79 EP300 (0.40) EP300HDAC6MEN1KMT2AALDH1A1
SCHEMBL12428264 0.79 EP300 (0.40) EP300HDAC6MEN1KMT2AALDH1A1
SCHEMBL12428430 0.78 SCN9A (0.42) EP300HDAC6MEN1KMT2AALDH1A1
SCHEMBL12428432 0.77 KAT8 (0.45) EP300HDAC6MEN1KMT2AALDH1A1
SCHEMBL14289166 0.76 EP300 (0.35) EP300HDAC6MEN1KMT2AALDH1A1
SCHEMBL14289164 0.76 KDM4E (0.33) EP300HDAC6MEN1KMT2AALDH1A1
SCHEMBL12428436 0.75 MEN1 (0.48) EP300HDAC6MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090084441-A1 Dye-sensitized photoelectric conversion device CRY1, H1-5, H1-0 EP300 2442/4885HDAC6 4236/4885MEN1 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.